𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A long-term study of istradefylline in subjects with fluctuating Parkinson's disease

✍ Scribed by Stewart Factor; Margery H. Mark; Ray Watts; Lynn Struck; Akihisa Mori; Rocco Ballerini; Neil M. Sussman

Book ID
116820766
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
164 KB
Volume
16
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Study of istradefylline in patients with
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
✍ Robert A. Hauser; Lisa M. Shulman; Joel M. Trugman; John W. Roberts; Akihisa Mor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a

Efficacy of long-term continuous subcuta
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
✍ Pedro J. GarcΓ­a Ruiz; Ángel Sesar Ignacio; BegoΓ±a Ares Pensado; Alfonso Castro G πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Abstract Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long‐term treated with CSAI. We reviewed data from 82 patie